|Articles|April 1, 2005
Pharmaceutical Technology Europe
- Pharmaceutical Technology Europe-04-01-2005
- Volume 17
- Issue 4
Maintaining the Safety of EU Drugs
Author(s)Andrew Jackson
How important will anticounterfeiting measures become to protect the European pharma industry?
Advertisement
Articles in this issue
over 20 years ago
Nanotechnology Applications for Drug Deliveryover 20 years ago
Nanotech Not Big Enough for Pharma?over 20 years ago
Protecting Intellectual Property Prior to Commercializationover 20 years ago
Ion Exchange Resinates — The Technology Behind the Mysteryover 20 years ago
Defining The BordersNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge
2
Why Context Matters in Validating Biomarker Assays for Bioanalysis
3
Targeted high resolution metabolite screening workflows
4
Application of alternative electron-based fragmentation for identification of drug metabolites and quantification of complex peptide therapeutics
5
